» Articles » PMID: 22449238

The Effect of Mouse Strain on Herpes Simplex Virus Type 1 (HSV-1) Infection of the Central Nervous System (CNS)

Overview
Journal Herpesviridae
Publisher Biomed Central
Date 2012 Mar 28
PMID 22449238
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mice infected with HSV-1 can develop lethal encephalitis or virus induced CNS demyelination. Multiple factors affect outcome including route of infection, virus and mouse strain. When infected with a sub-lethal dose of HSV-1 strain 2 via the oral mucosa, susceptible SJL/J, A/J, and PL/J mice develop demyelinating lesions throughout the brain. In contrast, lesions are restricted to the brainstem (BST) in moderately resistant BALB/c mice and are absent in resistant BL/6 mice. The reasons for the strain differences are unknown.

Methods: In this study, we combine histology, immunohistochemistry, and in-situ hybridization to investigate the relationship between virus and the development of lesions during the early stage (< 24 days PI) of demyelination in different strains of mice.

Results: Initially, viral DNA and antigen positive cells appear sequentially in non-contiguous areas throughout the brains of BALB/c, SJL/J, A/J, and PL/J mice but are restricted to an area of the BST of BL/6 mice. In SJL/J, A/J, and PL/J mice, this is followed by the development of 'focal' areas of virus infected neuronal and non-neuronal cells throughout the brain. The 'focal' areas follow a hierarchical order and co-localize with developing demyelinating lesions. When antigen is cleared, viral DNA positive cells can remain in areas of demyelination; consistent with a latent infection. In contrast, 'focal' areas are restricted to the BST of BALB/c mice and do not occur in BL/6 mice.

Conclusions: The results of this study indicate that susceptible mouse strains, infected with HSV-1 via the oral mucosa, develop CNS demyelination during the first 24 days PI in several stages. These include: the initial spread of virus and infection of cells in non-contiguous areas throughout the brain, the development of 'focal' areas of virus infected neuronal and non-neuronal cells, the co-localization of 'focal' areas with developing demyelinating lesions, and latent infection in a number of the lesions. In contrast, the limited demyelination that develops in BALB/c and the lack of demyelination in BL/6 mice correlates with the limited or lack of 'focal' areas of virus infected neuronal and non-neuronal cells in these two strains.

Citing Articles

, Neurodegenerative Disorders and Autoimmune Diseases: What Is the Relationship between Them?.

De Francesco M Viruses. 2024; 16(1).

PMID: 38257833 PMC: 10818483. DOI: 10.3390/v16010133.


Alzheimer's disease and multiple sclerosis: a possible connection through the viral demyelinating neurodegenerative trigger (vDENT).

Boukhvalova M, Kastrukoff L, Blanco J Front Aging Neurosci. 2023; 15:1204852.

PMID: 37396655 PMC: 10310923. DOI: 10.3389/fnagi.2023.1204852.


Cathelicidin-derived antiviral peptide inhibits herpes simplex virus 1 infection.

Guo X, An Y, Tan W, Ma L, Wang M, Li J Front Microbiol. 2023; 14:1201505.

PMID: 37342565 PMC: 10277505. DOI: 10.3389/fmicb.2023.1201505.


Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers.

Kang K, Bernstock J, Totsch S, Gary S, Rocco A, Nan L Clin Cancer Res. 2022; 28(24):5419-5430.

PMID: 36239623 PMC: 9771977. DOI: 10.1158/1078-0432.CCR-22-1382.


Efficacy and safety of a third-generation oncolytic herpes virus G47Δ in models of human esophageal carcinoma.

Yajima S, Sugawara K, Iwai M, Tanaka M, Seto Y, Todo T Mol Ther Oncolytics. 2021; 23:402-411.

PMID: 34853811 PMC: 8605086. DOI: 10.1016/j.omto.2021.10.012.


References
1.
Kastrukoff L, Long C, Doherty P, WROBLEWSKA Z, KOPROWSKI H . Isolation of virus from brain after immunosuppression of mice with latent herpes simplex. Nature. 1981; 291(5814):432-3. DOI: 10.1038/291432a0. View

2.
Sequiera L, Jennings L, Carrasco L, Lord M, Curry A, Sutton R . Detection of herpes-simplex viral genome in brain tissue. Lancet. 1979; 2(8143):609-12. DOI: 10.1016/s0140-6736(79)91667-2. View

3.
Wakisaka H, Hato N, Honda N, Takahashi H, Kisaki H, Murakami S . Demyelination associated with HSV-1-induced facial paralysis. Exp Neurol. 2002; 178(1):68-79. DOI: 10.1006/exnr.2002.8035. View

4.
Sun N, Cassell M, Perlman S . Anterograde, transneuronal transport of herpes simplex virus type 1 strain H129 in the murine visual system. J Virol. 1996; 70(8):5405-13. PMC: 190498. DOI: 10.1128/JVI.70.8.5405-5413.1996. View

5.
Fraser N, LAWRENCE W, WROBLEWSKA Z, Gilden D, KOPROWSKI H . Herpes simplex type 1 DNA in human brain tissue. Proc Natl Acad Sci U S A. 1981; 78(10):6461-5. PMC: 349059. DOI: 10.1073/pnas.78.10.6461. View